Business Context and Reporting Period
Retractable Technologies, Inc. (RVP) filed this Form 8-K on May 1, 2020, to report a significant contract award. The company, incorporated in Texas, manufactures automated retraction safety syringes.
Key Financial Metrics
This filing does not provide comprehensive financial statements, revenue, profit, cash flow, or debt metrics. The primary financial data point disclosed is the value of a specific new contract.
- New Contract Value: $83,788,439.80 (Fixed price delivery order).
- Contracting Agency: U.S. Department of Health and Human Services.
- Product: Automated retraction safety syringes.
Material Changes
The material change reported is the award of a delivery order under an existing government contract. This represents a significant addition to the company's order book for the reporting period.
Guidance, Outlook, and Risks
Management provided forward-looking statements regarding the execution of this contract but noted several risks that could cause actual performance to differ materially from expectations:
- Operational Risks: Ability to ramp up domestic production and staffing.
- Supply Chain: Availability of raw materials and finished goods from suppliers; transportation issues.
- Financial Risks: Ability to maintain liquidity.
- External Factors: Potential tariffs, foreign trade risk, and the impact of the global COVID-19 pandemic on logistics, operations, and costs.
Investor Verification Checklist
- Verify the company's current liquidity position to ensure it can fund the production ramp-up required for the $83.8 million order.
- Confirm the timeline for delivery and revenue recognition associated with this specific delivery order.
- Assess the status of raw material supply chains and staffing levels in light of the COVID-19 pandemic.
- Review subsequent filings for updates on the execution of this contract and any potential delays.